Porphyria cutanea tarda in a hemodialysis patient with hepatitis C virus: efficacy of treatment with multiple phlebotomies and erythropoietin.
Mohamed Amine
MA
Hamzi
Ahmed
A
Alayoud
Mohamed
M
Asseraji
Ismail
I
Akhmouch
Zouhair
Z
Oualim
D003937:Diagnosis, Differential; D004305:Dose-Response Relationship, Drug; D004921:Erythropoietin / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D016174:Hepacivirus / Q000276:immunology; D018937:Hepatitis C Antibodies / Q000032:analysis; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000821:virology; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy*; D008875:Middle Aged; D018962:Phlebotomy / Q000379:methods*; D017119:Porphyria Cutanea Tarda / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D006435:Renal Dialysis / Q000009:adverse effects*
D018937:Hepatitis C Antibodies; D004921:Erythropoietin